Search Results - "Kazuko Kamiyama"
-
1
β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells
Published in Journal of pharmacological sciences (01-01-2020)“…Ketone bodies, including acetoacetate and β-hydroxybutyrate (βOHB), are produced from acetyl coenzyme A in the liver and then secreted into the blood. These…”
Get full text
Journal Article -
2
Dichloroacetate reduces cisplatin-induced apoptosis by inhibiting the JNK/14-3-3/Bax/caspase-9 pathway and suppressing caspase-8 activation via cFLIP in murine tubular cells
Published in Scientific reports (16-10-2024)“…Cisplatin-induced injury to renal proximal tubular cells stems from mitochondrial damage-induced apoptosis and inflammation. Dichloroacetate (DCA), a pyruvate…”
Get full text
Journal Article -
3
Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways
Published in Biochimica et biophysica acta. Molecular and cell biology of lipids (01-06-2020)“…Short-chain fatty acids (SCFAs), including acetate, butyrate, and propionate, are produced when colonic bacteria in the human gastrointestinal tract ferment…”
Get full text
Journal Article -
4
Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice
Published in Nephrology, dialysis, transplantation (01-10-2020)“…Abstract Background Chronic hypoxia may play a pivotal role in the development of diabetic nephropathy (DN). However, the precise mechanisms underlying…”
Get full text
Journal Article -
5
A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells
Published in Oncotarget (31-07-2018)“…Short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate are generated by microbial fermentation of indigestible fiber by gut flora. SCFAs are…”
Get full text
Journal Article -
6
PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells
Published in Clinical and experimental nephrology (01-06-2021)“…Background Cisplatin-induced injury of renal proximal tubular cells results basically from increased apoptosis via mitochondrial damage, and is mitigated by…”
Get full text
Journal Article -
7
AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis via HDAC inhibition
Published in Therapeutic advances in medical oncology (2020)“…Background: Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide and establishment of new chemotherapies for HCC is urgently needed. GPR41…”
Get full text
Journal Article -
8
PPAR-α Insufficiency Enhances Doxorubicin-Induced Nephropathy in PPAR-α Knockout Mice and a Murine Podocyte Cell Line
Published in Cells (Basel, Switzerland) (28-08-2024)“…Peroxisome proliferator-activated receptor-alpha (PPAR-α) and its exogenous activators (fibrates) promote autophagy. However, whether the deleterious effects…”
Get full text
Journal Article -
9
Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells
Published in Hypertension research (01-05-2014)“…Telmisartan, an angiotensin II receptor type 1 blocker (ARB), was recently reported to promote lipolysis in mice by acting as a peroxisome…”
Get full text
Journal Article -
10
Fenofibrate reduces cisplatin-induced apoptosis by inhibiting the p53/Puma/Caspase-9 pathway and the MAPK/Caspase-8 pathway rather than by promoting autophagy in murine renal proximal tubular cells
Published in Biochemistry and biophysics reports (01-07-2022)“…The main lesion of cisplatin nephrotoxicity is damage to proximal tubular cells due to increased apoptosis via the mitochondrial and death receptor pathways,…”
Get full text
Journal Article -
11
Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells
Published in Clinical and experimental nephrology (01-02-2011)“…Background Glucocorticoid (GC) treatment reportedly exaggerates renal fibrosis in progressive kidney diseases during which hypoxia occurs as an unavoidable…”
Get full text
Journal Article -
12
Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells
Published in Biochemical and biophysical research communications (29-04-2017)“…Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, are produced predominantly by gut microbiota fermentation of dietary fiber. SCFAs…”
Get full text
Journal Article -
13
β-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells
Published in Life sciences (1973) (01-04-2019)“…β-Hydroxybutyrate (βOHB) is a metabolic intermediate that constitutes about 70% of ketone bodies produced in liver from oxidation of fatty acids released from…”
Get full text
Journal Article -
14
-
15
Elevated Levels of Urinary Extracellular Vesicle Fibroblast-Specific Protein 1 in Patients with Active Crescentic Glomerulonephritis
Published in Nephron (2015) (01-01-2019)“…Extracellular vesicles (EVs), including exosomes, are present in various bodily fluids, including urine. We and others previously reported that cells…”
Get more information
Journal Article -
16
Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells
Published in Biochemical and biophysical research communications (14-11-2014)“…•TNF-α increased VEGF-C expression by enhancing phosphorylation of p38MAPK and HSP27.•Telmisartan decreased TNF-α-stimulated expression of VEGF-C.•Telmisartan…”
Get full text
Journal Article -
17
AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis HDAC inhibition
Published in Therapeutic advances in medical oncology (01-03-2020)“…Background: Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide and establishment of new chemotherapies for HCC is urgently needed. GPR41…”
Get full text
Journal Article -
18
Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association
Published in Lipids in health and disease (17-03-2016)“…Statins decrease cholesteryl ester transfer protein (CETP) levels, which have been positively associated with hepatic lipid content as well as serum low…”
Get full text
Journal Article -
19
Dexamethasone enhances basal and TNF-α-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11β-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells
Published in Nephrology, dialysis, transplantation (01-06-2009)“…Background. Long-term treatment with glucocorticoids (GCs) reportedly exaggerates renal fibrosis in chronic progressive inflammatory kidney disease. GCs induce…”
Get full text
Journal Article -
20
Dexamethasone enhances basal and TNF-[alpha]-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11[beta]-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells
Published in Nephrology, dialysis, transplantation (01-06-2009)“…Background. Long-term treatment with glucocorticoids (GCs) reportedly exaggerates renal fibrosis in chronic progressive inflammatory kidney disease. GCs induce…”
Get full text
Journal Article